Applied Genetic Technologies (NASDAQ: AGTC) Climbs Weeks After Collaboration With Otonomy

Applied Genetic Technologies Corporation (NASDAQ: AGTC) was one of the top gainers at the close of the week. It closed the week with gains of...

Axsome Therapeutics Inc (NASDAQ: AXSM) Rallies After Announcing Intentions to Sell Common Stock

Axsome Therapeutics Inc (NASDAQ: AXSM) was a top gainer in Wednesday’s trading session after it closed the day with gains of 10.62%. The stock has...

Verb Technology Company (NASDAQ: VERB) Gains After Appointing Judith Hammerschmidt to Its Board

Verb Technology Company Inc (NASDAQ: VERB) recorded gains in Monday’s trading session and has sustained the same in early morning trading, today. This is after...

BiondVax Pharmaceuticals (NASDAQ: BVXV) Sustains Rally Weeks After Announcing Phase 3 Trial for Influenza...

BiondVax Pharmaceuticals Ltd (NASDAQ: BVXV) was a top gainer at the close of the week. The stock closed the day with gains of 19.62%. This...

Assembly Biosciences Inc (NASDAQ: ASMB) Attracts Wall Street Investors After Pricing its Public Offer

Assembly Biosciences Inc (NASDAQ: ASMB) has been gaining upside momentum since late October. In yesterday’s session, it rallied to close the day with gains of...

Viela Bio Inc (NASDAQ: VIE) Makes Key Progress in Phase 2b Trial For VIB4920

Viela Bio Inc (NASDAQ: VIE) has been on an upside trajectory since it went public in October. The company went public at an offer price...

Rocket Pharmaceutical (NASDAQ: RCKT) Trades Higher on Encouraging Phase 1 Trials for RP-L102

Rocket Pharmaceutical Inc (NASDAQ: RCKT) was a big gainer in Friday’s trading session, and closed the day with gains of 13.47%. This followed news that...

Cloudflare Inc (NYSE: NET) Sustains Value Growth, a Month After Strong Q3 Results

Cloudflare Inc (NYSE: NET) has been gaining for the past month. In Friday’s trading session, the stock closed the day in positive territory and was...

10X Genomics Inc (NASDAQ: TXG) Expects Full-Year Revenues to Grow by 63% to 65%...

10X Genomics Inc (NASDAQ: TXG) has experienced exponential growth since it went public in September. The stock went public at $39 a share and as...

Bristol-Myers Squibb Company (NYSE: BMY) Gets FDA Breakthrough Designation for ORENCIA

Bristol-Myers Squibb Company (NYSE: BMY) has been on an uptrend for the better part of H2 of 2019. The company has had a series of...

Must Read